COMMUNIQUÉS West-GlobeNewswire

Opus Genetics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
28/05/2026
RESEARCH TRIANGLE PARK, N.C., May 28, 2026 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients [...]
rYojbaba Rings the Nasdaq Stock Market Opening Bell, Celebrating Its Mission to “Fight Poverty” on the Global Stage
28/05/2026
CEO Ryoji Baba shares the company’s vision of combining the Samurai Spirit with AI and technology to break language barriers and create opportunities for the next generation FUKUOKA, Japan, May 28, 2026 (GLOBE NEWSWIRE [...]
Keeps TRT Claims Evaluated: Clinician-Prescribed Testosterone Replacement Therapy Medication Online
28/05/2026
Compounded Testosterone Medication, Injectable TRT, Oral TRT, Enclomiphene Off-Label, Lab Panel, FDA Status, Pricing, and Telehealth Prescribing Rules (2026) New York, NY, May 28, 2026 (GLOBE NEWSWIRE) -- Compounded [...]
Kailera Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference
28/05/2026
WALTHAM, Mass., May 28, 2026 (GLOBE NEWSWIRE) -- Kailera Therapeutics, Inc. (Nasdaq: KLRA), a clinical-stage biotechnology company focused on elevating the next era of obesity care, today announced that Ron Renaud, [...]
Parexel to Present Real-World Oncology Research and Launch New Patient-Focused Campaign at ASCO 2026
28/05/2026
Two virtual posters accepted exploring rejections in oncology marketing applications and real-world pulmonary safety of T-DXd in HER2-positive metastatic breast cancer From Insights to Life campaign reinforces Parexel’s [...]
Tarsus to Participate in Upcoming Investor Conferences
28/05/2026
IRVINE, Calif., May 28, 2026 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that management plans to participate in the following upcoming investor conferences: William Blair 46 th [...]
San Antonio Authentic Counseling Expands Veteran Mental Health Accessibility Efforts in Military City USA
28/05/2026
Founded by veteran therapist Steven Flint, LCSW, the San Antonio practice is raising awareness about the growing demand for faster, more accessible therapy resources for veterans and military families. San Antonio, TX, [...]
Pelthos Therapeutics to Participate in 2026 Jefferies Global Healthcare Conference
28/05/2026
DURHAM, N.C., May 28, 2026 (GLOBE NEWSWIRE) -- Pelthos Therapeutics Inc. (NYSE American: PTHS), a biopharmaceutical company committed to commercializing innovative therapeutic products for unmet patient needs, (“Pelthos [...]
Taurus Meds TRT Claims Evaluated: Powerful Testosterone Replacement Therapy & Taurus Charge ED Medication
28/05/2026
Online TRT Blood Work Through LabCorp and Quest Diagnostics, Sublingual 4-in-1 ED Medication, Prescription Access, and Pricing Explained Wilmington, DE, May 28, 2026 (GLOBE NEWSWIRE) -- Compounded medications are not [...]
Assembly Biosciences Announces Upcoming Investor Conference Presentations
28/05/2026
SOUTH SAN FRANCISCO, Calif., May 28, 2026 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative therapeutics targeting serious viral and liver diseases, today [...]
Medline Inc. announces closing of upsized secondary offering of Class A common stock
28/05/2026
NORTHFIELD, Ill., May 28, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (Nasdaq: MDLN) (“Medline”) announced today that it has closed its upsized secondary offering of 72,554,594 shares of Medline Inc.’s Class A common stock by [...]
LB Pharmaceuticals to Participate in Upcoming June Investor Events
28/05/2026
NEW YORK, May 28, 2026 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), a late-stage biopharmaceutical company developing novel therapies for schizophrenia, bipolar [...]
Emergent BioSolutions Receives $64.5 Million Contract Modification for BAT® [Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) – (Equine)] to Support U.S. Biodefense Strategy
28/05/2026
GAITHERSBURG, Md., May 28, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced it has been awarded a contract modification valued at approximately $64.5 million from the Administration for [...]
Regeneron’s Ebola Antibody Recommended by World Health Organization for Investigational Use in Response to Current Bundibugyo Ebolavirus Outbreak
28/05/2026
Inmazeb ® (a three-antibody cocktail consisting of maftivimab, atoltivimab and odesivimab-ebgn) was the first Ebola treatment approved by the U.S. Food and Drug Administration, indicated specifically for the [...]
Sequana Medical announces results of Annual General Meeting of Shareholders
28/05/2026
Ghent, Belgium, May 28, 2026 (GLOBE NEWSWIRE) -- PRESS RELEASE | REGULATED INFORMATION | 28 May 2026, 9:00 pm CEST Ghent, Belgium – 28 May 2026 – Sequana Medical NV (Euronext Brussels: SEQUA) (the " Company " or " [...]
Editas Medicine Announces Updated Presentation Time for Upcoming Investor Conference
28/05/2026
CAMBRIDGE, Mass., May 28, 2026 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company focused on developing transformative medicines for serious diseases, today announced that it [...]
Tonix Pharmaceuticals Presented Retrospective U.S. Real-World Claims Analysis of Opioid Use in Patients with Fibromyalgia at the 2026 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting
28/05/2026
Real-world analysis of three years of closed claims data from Symphony Health, focused on the third year of the study (2023-2024), comprised of more than 261,000 U.S. adults with fibromyalgia Data demonstrate a [...]
Outlook Therapeutics Announces Pricing of $5.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
28/05/2026
ISELIN, N.J., May 28, 2026 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on the development and commercialization of ONS-5010/LYTENAVA™ (bevacizumab-vikg, bevacizumab [...]
Tevogen Advances Strategic Acquisition Initiatives with Potential to Support Approximately $100 Million in Combined Annual Revenue
28/05/2026
WARREN, N.J., May 28, 2026 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN ) today announced continued progress across its strategic acquisition initiatives intended to complement [...]

Pages